Generalized Pustular Psoriasis Induced by Infliximab in a Patient With Inflammatory Bowel Disease

The incidence of anti–tumour necrosis factor (TNF)–induced psoriasiform eruptions has ranged in the literature between 0.5% and 10.9% of patients with inflammatory bowel disease (IBD). The morpholo...